Menu Back to Committee

Programme Steering Committee, Advisors and Topic Leaders

Introducing the DIA Europe 2018 Programme Steering Committee

REGULATORY SCIENCE CO-CHAIRS:

Pani Luca Luca Pani
Professor, Department of Psychiatry and Behavioral Sciences, University Of Miami School Of Medicine; Executive Director of Global Medical Innovation NeuroCog, USA


Michelle Rohrer
Michelle Rohrer
Global Head of PD Regulatory and Policy
F. Hoffmann-La Roche and Genentech, Switzerland


VALUE & ACCESS CO-CHAIRS:

Jens Grueger Jens Grueger
Head of Global Pricing & Market Access
F. Hoffmann-La Roche, Switzerland


Ad Schuurman
A.R. (Ad) Schuurman
Head of International Department
National Health Care Institute (ZIN), Netherlands


TRANSLATIONAL MEDICINE & SCIENCE CHAIR:

Salah Dine Chibout
Salah-Dine Chibout
Global Head of Discovery & Investigative Safety (DIS)
Novartis Institutes, Switzerland

Program Committee

  • Salah-Dine  Chibout
    Salah-Dine Chibout Global Head Discovery & Investigative Safety/Preclinical Safety Therapeutic Area
    Novartis Pharma AG, Switzerland
  • Jens  Grueger, PhD
    Jens Grueger, PhD Global Market Access Expert
    Former President at ISPOR, Switzerland
  • Luca  Pani, MD
    Luca Pani, MD Former, AIFA; Professor, Department of Psychiatry and Behavioral Sciences
    University of Miami, United States
  • Michelle  Rohrer, PhD
    Michelle Rohrer, PhD Senior Vice President, Global Head of Product Development Regulatory and Policy
    Genentech, A Member of the Roche Group, United States
  • Vivianne  Arencibia
    Vivianne Arencibia Independent Consultant
    Arencibia Quality and Compliance Associates, United States
  • Sabine  Atzor, MPharm, RPh
    Sabine Atzor, MPharm, RPh Head of EU Regulatory Policies
    F. Hoffmann-La Roche Ltd, Switzerland
  • Ursula  Busse, PhD, MBA
    Ursula Busse, PhD, MBA Head of Regulatory Intelligence & Policy
    Boehringer Ingelheim, Germany
  • João  Duarte, MPharm, MSc
    João Duarte, MPharm, MSc Director, Business Planning & Operations, Global Regulatory Affairs, R&D and Com
    Alexion, Astrazeneca Rare Disease, France
  • Sabine  Haubenreisser, PhD, MSc
    Sabine Haubenreisser, PhD, MSc Principal Scientific Administrator, Stakeholders and Communication Division
    European Medicines Agency, Netherlands
  • Cordula  Landgraf, RPh
    Cordula Landgraf, RPh Head of Networking
    Swissmedic, Switzerland
  • Francesco  Pignatti, MD
    Francesco Pignatti, MD Head of Oncology and Hematology
    European Medicines Agency, Netherlands
  • Bettina  Ryll
    Bettina Ryll Member of the First EU Cancer Mission Board
    MPNE, Vision Zero Cancer, Sweden
  • Claudine  Sapède, PharmD
    Claudine Sapède, PharmD Director, Global HTA Policy
    Novartis Pharma AG, Switzerland
  • Ad  Schuurman, MBA, MSc
    Ad Schuurman, MBA, MSc Head of the Business Contact Centre & International Affairs
    National Health Care Institute (ZIN), Netherlands
  • Indranil  Bagchi, PhD, MSc
    Indranil Bagchi, PhD, MSc Senior Vice President and Head, Global Value and Access
    Novartis Oncology, United States
  • Isabelle  de Zegher, DrMed, MD, MS, MSc
    Isabelle de Zegher, DrMed, MD, MS, MSc Founder
    b!loba, Belgium
  • Petra  Doerr, PharmD, RPh
    Petra Doerr, PharmD, RPh Director (Designate)
    European Directorate for the Quality of Medicines & HealthCare (EDQM), France
  • Vicki  Edwards
    Vicki Edwards Vice President, Pharmacovigilance Excellence and International QPPV
    AbbVie, Inc., United Kingdom
  • Georgy  Genov, MD
    Georgy Genov, MD Head of Pharmacovigilance Office, Quality and Safety of Medicines Department
    European Medicines Agency, Netherlands
  • Tony  Humphreys, MPharm
    Tony Humphreys, MPharm Head of the Regulatory Science and Innovation Task Force
    European Medicines Agency, Netherlands
  • Merete  Joergensen, MBA, MSc
    Merete Joergensen, MBA, MSc Clinical Disclosure and Transparency Expert, Former EFPIA, CREG Clinical Trials
    Independent, Denmark
  • Jordi  Llinares Garcia, MS
    Jordi Llinares Garcia, MS Head of Research and Innovation
    European Medicines Agency, Netherlands
  • Manfred  Maeder, PhD
    Manfred Maeder, PhD Head of Device Development & Commercialization
    Novartis, Switzerland
  • Thomas  Metcalfe, MBA
    Thomas Metcalfe, MBA Personalised Healthcare Ecosystems
    F. Hoffmann-La Roche, Switzerland
  • Sharon  Olmstead
    Sharon Olmstead Global Head, Regulatory & Development Policy
    Novartis Pharmaceuticals Corporation, United States
  • Not Confirmed
    Representative Invited Merck KGaA, Germany
  • Thomas  Senderovitz, DrMed, MD
    Thomas Senderovitz, DrMed, MD Senior Vice President, Data Science
    NovoNordisk, Denmark
  • Not Confirmed
    Representative Invited European Medicines Agency, Netherlands
Load More